Compounds of formula (I)
are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions of compounds of formula (I), methods for using such compounds and compositions, and a process for preparing the compounds.
化合物的公式(I)在治疗受
组织胺-3受体
配体预防或改善的病症或疾病方面很有用。还披露了化合物的公式(I)的药物组合物、使用这种化合物和组合物的方法,以及制备这些化合物的过程。